Biomarkers of Kidney Diseases
Biomarkers can be utilized clinically to screen for, analyze, or screen the activity of diseases and to manage molecularly focused on treatment or survey therapeutic response. Glomerular filtration rate (GFR) remains the perfect marker of kidney function. Consolidating creatinine, CysC and urine albumin to creatinine proportion improves chance stratification for kidney infection movement and mortality. Kidney damage atom and neutrophil gelatinase-related lipocalin are viewed as sensible biomarkers in urine and plasma to determine severity and prognosis of CKD.
Related Conference of Biomarkers of Kidney Diseases
October 29-30, 2026
14th European Congress on Nephrology, Internal Medicine and Kidney Diseases
Paris, France